Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICAS-MT: Angio-FF Guided Stenting vs Medical Therapy for Intracranial Atherosclerosis
NCT05974033Not yet recruiting
- Sponsor
- Changhai Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2025
01
Overview
Randomised, open-label trial in intracranial atherosclerosis (ICAD) (2 arms), sponsored by Changhai Hospital. Primary endpoint: Stroke or death at 1 year. Planned start Aug 2023; status: not yet recruiting.
02
Conditions
intracranial atherosclerosis (ICAD)
Beyond the preview
Go deeper on NCT05974033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05974033.